http://www.mmm-online.com/product-launch/topic/2088/ Articles tagged with Product Launch from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The company's first-ever road show has stimulated sales for its new ClinicalKey reference tool, grabbing the attention of time-harried doctors for as long as 30 minutes during the workday. http://www.mmm-online.com/elsevier-samples-experiential-marketing/article/270780/ Mon, 03 Dec 2012 17:17:49 GMT The company's first-ever road show has stimulated sales for its new ClinicalKey reference tool, grabbing the attention of time-harried doctors for as long as 30 minutes during the workday. MMM New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta? http://www.mmm-online.com/branded-benlysta-dtc-campaign-ready-to-roll-out/article/215338/ Wed, 26 Oct 2011 17:06:37 GMT New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta? MMM Roche will help promote Merck's newly approved hepatitis C drug Victrelis (boceprevir) under a strategic partnership that may help bolster the firms' chances in an upcoming market share battle. The agreement stunned Wall Street, since Merck and Roche already sell rival versions of a standard hepatitis C treatment. http://www.mmm-online.com/roche-to-co-promote-mercks-victrelis-in-us/article/203083/ Tue, 17 May 2011 20:01:50 GMT Roche will help promote Merck's newly approved hepatitis C drug Victrelis (boceprevir) under a strategic partnership that may help bolster the firms' chances in an upcoming market share battle. The agreement stunned Wall Street, since Merck and Roche already sell rival versions of a standard hepatitis C treatment. MMM Vertex said it stands ready to market hepatitis C drug telaprevir, under the brand name Incivek, and its approval could come as early as this month. http://www.mmm-online.com/vertex-ready-to-put-200-in-field-for-hep-c-drug-launch/article/202199/ Thu, 05 May 2011 18:58:01 GMT Vertex said it stands ready to market hepatitis C drug telaprevir, under the brand name Incivek, and its approval could come as early as this month. MMM When co-marketers Human Genome Sciences and GlaxoSmithKline launch newly approved lupus drug Benlysta later this month, reps will be able to tout a broad label. http://www.mmm-online.com/gsk-hgs-cleared-to-launch-lupus-drug-with-unrestricted-label/article/198060/ Thu, 10 Mar 2011 16:34:43 GMT When co-marketers Human Genome Sciences and GlaxoSmithKline launch newly approved lupus drug Benlysta later this month, reps will be able to tout a broad label. MMM Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call. http://www.mmm-online.com/savient-focuses-on-reimbursement-for-krystexxa-launch/article/197319/ Tue, 01 Mar 2011 18:31:09 GMT Savient Pharmaceuticals launched Krystexxa (pegloticase), an orphan drug for chronic gout, on Monday, and deployed a mix of sales reps, education specialists and business managers to help expedite reimbursement from payers, executives said on a conference call. MMM Amgen received FDA approval for a higher dose of its denosumab injection, Xgeva, which puts the drug in competition with Novartis' Zometa (zoledronic acid) for the prevention of bone damage in patients with certain types of cancer. A lower dose of denosumab, Prolia, was approved by FDA in June for osteoporosis. http://www.mmm-online.com/fda-approval-pits-amgens-denosumab-against-novartis-zometa/article/191465/ Mon, 22 Nov 2010 22:05:50 GMT Amgen received FDA approval for a higher dose of its denosumab injection, Xgeva, which puts the drug in competition with Novartis' Zometa (zoledronic acid) for the prevention of bone damage in patients with certain types of cancer. A lower dose of denosumab, Prolia, was approved by FDA in June for osteoporosis. MMM Ferring Pharmaceuticals is launching its first branded TV ad with spots for its Lysteda treatment for heavy menstrual bleeding. The company had to soothe some network execs who at first balked at the ad's blunt talk of the condition. http://www.mmm-online.com/lysteda-tv-ads-make-some-networks-squeamish/article/181348/ Wed, 20 Oct 2010 19:35:10 GMT Ferring Pharmaceuticals is launching its first branded TV ad with spots for its Lysteda treatment for heavy menstrual bleeding. The company had to soothe some network execs who at first balked at the ad's blunt talk of the condition. MMM AstraZeneca has launched a professional site for its Vimovo arthritis drug that features a live chat option. http://www.mmm-online.com/astrazeneca-site-offers-docs-live-chat-with-reps/article/180347/ Mon, 04 Oct 2010 21:22:23 GMT AstraZeneca has launched a professional site for its Vimovo arthritis drug that features a live chat option. MMM As the number of FDA-approved fibromyalgia therapies has grown, so has patient hope. However, the condition is still not well understood by the medical community overall, hampering uptake of branded drugs approved for the disorder. http://www.mmm-online.com/slow-diagnosis-hampers-uptake-of-fibromyalgia-drugs/article/156224/ Mon, 26 Oct 2009 20:19:36 GMT As the number of FDA-approved fibromyalgia therapies has grown, so has patient hope. However, the condition is still not well understood by the medical community overall, hampering uptake of branded drugs approved for the disorder. MMM